Consumer staples stocks often sit in the background of portfolios, but the latest data from Arizona and national inflation trends put this sector back in focus. Phoenix households are still facing monthly expenses near $6,900, energy prices have dropped more than 6% in a month, and unemployment in Arizona is at 4.9%. Together, these forces can influence how much consumers spend and what they cut first. This article looks at 3 consumer staples stocks from our screener that appear closely exposed to these developments and explains why some investors are watching them more closely right now.

a2 Milk (NZSE:ATM)

Overview: The a2 Milk Company sells branded dairy products that use the A2-type protein, focusing on infant formula and other nutritional milks across Australia, New Zealand, China, wider Asia and the United States under its a2 Milk and a2 Platinum labels.

Operations: a2 Milk generates most of its revenue from China and other parts of Asia at about NZ$1.43b, with additional contributions from Australia and New Zealand at about NZ$328m and the United States at about NZ$158m.

Market Cap: NZ$6.0b

Investors watching consumer staples in a period of high household costs may find a2 Milk interesting because it sits in essential nutrition, yet carries a rich P/E multiple and a share price that some models still place well below estimated fair value. The company is pushing deeper into China and other Asian markets, funding new products and manufacturing while also dealing with margin pressure, air freight costs and a recent US infant formula recall announced for July 2026. At the same time, high quality earnings, strong cash generation and a large special dividend signal confidence from management. The key consideration is whether a2 Milk can convert this expansion into sustainable returns without letting competition and higher funding risk erode the story.

a2 Milk sits at the intersection of essential nutrition and high expectations, with a rich P/E, China expansion and a special dividend all pulling in different directions. Get the full story in the 3 key rewards and 1 important warning sign

Bubs Australia (ASX:BUB)

Overview: Bubs Australia manufactures and sells infant formula, baby food and goat dairy products for both infants and adults, supplying everyday nutrition across Australia, China, the United States and other international markets under its Bubs and Caprilac brands.

Operations: Bubs Australia generates about A$109.5m in revenue from food processing, with key sales contributions from the USA at roughly A$64.2m, China at about A$18.4m, Australia at around A$18.8m and the rest of the world at approximately A$8.1m.

Market Cap: A$76.0m

Bubs Australia operates in essential infant nutrition, which can keep it relevant when household budgets are tight but spending on baby formula and food remains a priority. The company is building a premium position in goat milk-based products across the U.S. and Asia and is working on permanent FDA access in the U.S. In addition, recent appointments in the CFO role and on the board bring dairy and consumer brand experience. At the same time, reliance on key export markets, higher external funding and regulatory approvals adds risk if conditions or rules change. For investors, the mix of strategic ambitions, current profitability trends and these pressure points makes Bubs Australia a stock that some may choose to watch more closely in the consumer staples space.

Bubs Australia's push into premium goat milk formula and its pursuit of permanent FDA access could be masking a bigger story around future positioning and risk. Get the full analysis report for Bubs Australia

Vita Coco Company (COCO)

Overview: The Vita Coco Company develops, manufactures and markets coconut based drinks and dairy alternatives under the Vita Coco brand and related labels, selling coconut water, coconut milk, oil, juices and protein drinks across North America, Europe and other international markets. It also supplies private label coconut products to retailers and distributes through supermarkets, convenience stores, club channels, e commerce and foodservice partners.

Operations: Vita Coco generates about US$574.8m in revenue from the Americas and US$131.2m from International markets, with the United States accounting for roughly US$529.8m of sales and the United Kingdom about US$80.0m.

Market Cap: US$3.93b

Vita Coco sits at the intersection of consumer staples and health focused drinks, which helps explain why investors are watching it after a strong first half of 2026, a raised full year sales outlook of about US$797.5m and a Copra deal that pushes deeper into premium coconut water. The company reports high quality earnings, strong net margins and a P/E that is rich versus the wider beverage sector but below some faster growing peers. Buybacks and the Copra acquisition point to an active capital allocation play. On the risk side, Vita Coco still has heavy exposure to freight, tariffs and coconut sourcing costs, as well as higher SG&A and a concentrated category. The open question for investors is how long Vita Coco can keep this mix of growth, pricing power and cost pressures in balance.

Vita Coco’s rich P/E, Copra deal and buybacks point to a story that many investors may be only half seeing. Get the full picture with the analysis report for Vita Coco Company

The three consumer staples stocks in this article are just a starting point. The full screener surfaces 23 more companies in the Consumer Staples Stocks screener that carry equally compelling stories around essential products and pricing power. Use Simply Wall St to identify, analyze and filter for the specific catalysts and narratives that matter to you so you can focus on the highest conviction opportunities in this sector.

Take Control of Your Investment Journey

If a2 Milk or any of these companies sound like a great opportunity, register for FREE with Simply Wall St and add your companies to a Watchlist to monitor the share price against the fair value the ideal entry point. Once you've made your move, manage your holdings with our Portfolio Command Center that filters out the noise to deliver only the most critical, actionable updates. Throughout your journey, our Community allows you to filter the best ideas from thousands of investor perspectives. By uncovering hidden catalysts and risks early, you'll accelerate your decision-making and stay one step ahead of the market.

Seeking Fresh Alternatives Before They Fly

Fresh ideas do not stay under the radar for long. Stocks with building momentum can move from overlooked to crowded fast. Scan these curated shortlists while it matters and act now.

• Chase early upside potential in companies with strong balance sheets and resilient cash flows through a curated list of solid balance sheet and fundamentals (412 results) before others catch on.
• Spot high yield opportunities that could support long term income goals by reviewing a focused mix of 430 dividend fortresses while prices and payouts still look appealing.
• Ride the trend in applied AI by tracking a tight set of 69 profitable AI stocks that aren't just burning cash that already back their stories with real earnings instead of just hype.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.